Researchers in the United States have identified both antigen-specific and antigen non-specific predictive signatures of antibody responses to Moderna’s two-dose coronavirus disease 2019 (COVID-19) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback